Press Releases

Today the Biotechnology Industry Organization (BIO) announced the 2013 Pacific Rim Summit on Industrial Biotechnology and Bioenergy will be held October 8-11 at the Westin Gaslamp Quarter in San Diego, Calif. 

Industry leaders will discuss recent company successes and their biggest fears, and what’s ahead for the industry in 2013 

Ken Lisaius has been named Vice President of Communications at BIO.

BIO and the American Seed Trade Association (ASTA) are pleased with the continued support from key stakeholder groups on work related to patent expiration for biotechnology events.

More than 140 companies are expected to present their story.

Small Business Innovation Research grants provide critical support for emerging biotech companies working on cures and treatments.

The American Taxpayer Relief Act of 2012 extends for 2013 the $1.01 per gallon Second Generation Biofuel Producer Credit and the Special Allowance for Second Generation Biofuel Plant Property and modifies these credits to include both cellulosic and algae biofuel production.

Today, as part of its rigorous, scientific regulatory review governing genetically engineered (GE) animal technologies, the U.S. Food and Drug Administration (FDA) has released its draft Environmental Assessment of the genetically engineered (GE) AquAdvantage Salmon.

Members of the House and Senate Armed Services Committees finalized the National Defense Authorization Act of 2013 and cleared the path for the Department of Defense (DoD) to participate in public-private partnerships to build advanced biofuel biorefineries.

Today the Biotechnology Industry Organization (BIO) announced registration and housing are now open for the 2013 World Congress on Industrial Biotechnology and Bioprocessing. 

A coalition of organizations representing farmers, the advanced biofuels industry, fuel customers, and national security organizations today thanked Sen. Mark Udall (D-Colo.) and other co-sponsors for amending the National Defense Authorization Act of 2013.

BIO CEO & Investor Conference will be held February 11–12 in New York, NY.

The Environmental Protection Agency’s logic-based decision to uphold the Renewable Fuel Standard will protect America’s energy security and maintain the industry’s progress in commercializing advanced biofuels.

The Biotechnology Industry Organization (BIO) and the American Seed Trade Association (ASTA) announced today that the Generic Event Marketability and Access Agreement (GEMAA) is now effective. 

The Biotechnology Industry Organization (BIO) and the American Seed Trade Association (ASTA) announced today that the Generic Event Marketability and Access Agreement (GEMAA) is now open for signature.

BIO has extended its agreement for over five years with VWR International, LLC, a global distributor of laboratory supplies, equipment, chemicals and services for the life sciences industry.

The global event for biotech to take place in Chicago, IL April 22-25, 2013.

"Our children’s future rests upon our ability to shift as fast as possible to renewable energy sources. But we won’t succeed unless we can convince our political leaders that renewables are ready, reliable and competitive," Jim Greenwood, President & CEO of BIO, told attendees of RETECH 2012 during a keynote speech.

Any waiver of the RFS would have little to no effect on corn prices, but would certainly harm biofuel producers and biotechnology companies across the United States, BIO said today in official comments to the Environmental Protection Agency. 

The Biotechnology Industry Organization’s (BIO) 2012 Pacific Rim Summit on Industrial Biotechnology and Bioenergy will feature breakout sessions focused on using biomass to replace fossil fuels in creating bioenergy, biofuels and other bioproducts. 

Sessions to focus on new pharma-VC models for biotech investing, new corporate VC models and forecasting 2013 

Pharmaceutical Research and Manufacturers of America PhRMA President and CEO John J. Castellani and BIO President and CEO Jim Greenwood released the following joint statement on the implementation of the Prescription Drug User Fee Act (PDUFA V).

A large coalition of advanced and traditional renewable fuel stakeholders today joined forces to defend America’s Renewable Fuel Standard (RFS) and the economic, employment, domestic renewable energy and national security benefits the RFS provides.

Bill would stimulate capital formation for small biotech companies.